Global Oral Vaccines Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.

Scope of the Report:
This report focuses on the Oral Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
In the last several years, global market of oral vaccines developed rapidly, with an average growth rate of 6.31%. In 2017, global revenue of oral vaccines is nearly 2.01 billion USD; the actual consumption is about 2.2 billion doses.
The classification of oral vaccines includes rotavirus vaccine, cholera vaccine, oral polio vaccine and other types, and the sales proportion of polio vaccine in 2017 is about 94%, and the proportion is in decreasing trend from 2012 to 2017.
The worldwide market for Oral Vaccines is expected to grow at a CAGR of roughly 7.0% over the next five years, will reach 3010 million US$ in 2023, from 2010 million US$ in 2017, according to a new study.

Market Segment by Manufacturers, this report covers
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Others

Market Segment by Applications, can be divided into
Public
Private

There are 15 Chapters to deeply display the global Oral Vaccines market.
Chapter 1, to describe Oral Vaccines Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Oral Vaccines, with sales, revenue, and price of Oral Vaccines, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Oral Vaccines, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Oral Vaccines market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Oral Vaccines sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source